Market Overview The U.S. gastric cancer diagnostics market size was valued at USD 459.21 million in 2024 and is anticipated to register a CAGR of 7.4% from 2025 to 2034. This expansion is driven by advancements in diagnostic technologies, increased awareness of early detection, and the rising incidence of gastric cancer in the United States. Key Market Growth Drivers Advancements in...